Christopher Shelner

Time to appreciate Christopher Shelner. The guy’s a straight-up OG in the startup game, especially in biotech and AI. So, he’s part of YC W23, which is a big deal, right? That’s where the real movers and shakers get their start. Now, Christopher’s not just some random founder-he’s the COO and co-founder of Persist AI, a company that’s out here trying to shake up drug development with AI and cloud tech. Think about it-faster, cheaper, smarter ways to create long-acting injectables for chronic diseases. That’s huge, dude.

But here’s where it gets interesting. His background? It’s all about mechanics, automation, and making stuff tick. He’s got a grad degree in mechanical engineering, but he didn’t stop there. He’s been deep in the trenches as a program manager, working on electronics, automation, and manufacturing. So, he’s got this solid technical foundation plus real-world experience building systems that automate complex workflows. That’s a rare combo.

Before Persist, he jumped into the biotech space with Karthik Raman at Zymergen, working on automation for synthetic biology. Basically, they were building the tech to make biotech stuff more fast. That’s where he cut his teeth in high-stakes automation and innovation. And now, with Persist, he’s taking all that experience and applying it to something even bigger: transforming how we develop drugs.

What drives him? I think it’s clear-he’s all about pushing boundaries. He saw how slow and resource-heavy pharma can be, and he decided to do something about it. His team’s building custom automation systems that let them formulate drugs at lightning speed, slashing years off the process. That’s not just tech for tech’s sake; it’s about saving lives, making medicine more accessible, and tackling big problems in healthcare.

So, what’s the story here? Christopher’s process from mechanical engineering nerd to biotech innovator shows he’s someone who’s always chasing the future trend. He’s not content with the status quo. His experience in automation and biotech isn’t just a resume filler-it’s about a vision to make drug development faster, cheaper, better. And he’s already crushed it with Persist, raising millions and launching a cloud lab platform that’s the real deal.

Bottom line? This guy’s a mover and shaker, blending deep tech skills with a passion for fixing real-world problems. He’s the kind of founder who sees opportunity where others see bullshit, and he’s out here making shit happen. No cap.